IFI27 (interferon alpha inducible protein 27) is an interferon-stimulated gene that functions as a multifaceted adapter protein with critical roles in immune responses and disease pathogenesis. As a type I interferon-induced protein, IFI27 demonstrates distinct temporal expression patterns, showing delayed but sustained upregulation in myeloid cells during viral infections due to cell-specific epigenetic regulation 1. The protein serves as a biomarker for various pathological conditions, being commonly upregulated in infections, cancers, and inflammatory disorders 2. In autoimmune diseases, IFI27 is significantly elevated in systemic lupus erythematosus patients and may serve as a diagnostic marker 34. The protein plays important roles in apoptotic signaling pathways and cellular stress responses 5. In cancer contexts, IFI27 contributes to drug resistance mechanisms, with upregulation associated with docetaxel resistance in gastric cancer and promotion of angiogenesis in esophageal squamous cell carcinoma through exosomal pathways 67. Additionally, IFI27 is involved in kidney fibrosis progression, where transcription factor Nfix promotes its expression, leading to increased apoptosis and tissue damage 5. The protein's diverse functions across different biological processes make it a promising candidate for precision medicine applications.